How to administer insulin to a 13-year-old, 40 kg patient with diabetic ketoacidosis (DKA) and altered mental status?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Administration in Pediatric DKA with Altered Mental Status

Immediate Insulin Protocol

For a 13-year-old, 40 kg patient with DKA and altered mental status, administer continuous intravenous regular insulin at 0.1 units/kg/hour (4 units/hour) after confirming serum potassium ≥3.3 mEq/L, preceded by an optional IV bolus of 0.1 units/kg (4 units). 1, 2

Critical Pre-Insulin Checklist

Before starting any insulin therapy, you must:

  • Check serum potassium immediately - if K+ <3.3 mEq/L, do NOT start insulin under any circumstances, as this can cause fatal cardiac arrhythmias 1, 2
  • If K+ <3.3 mEq/L, aggressively replace potassium with 20-40 mEq/L in IV fluids until levels reach ≥3.3 mEq/L 1
  • Obtain ECG to assess for cardiac effects of hypokalemia 1
  • Confirm adequate urine output before potassium repletion 3

Step-by-Step Insulin Administration

Initial Dosing:

  • Give IV bolus of regular insulin 0.1 units/kg = 4 units (optional but recommended for moderate-severe DKA) 1, 2
  • Immediately start continuous IV infusion at 0.1 units/kg/hour = 4 units/hour 1, 2, 4
  • Use only regular insulin (not rapid-acting analogs) for IV infusion in critically ill patients with altered mental status 2

Target glucose decline: 50-75 mg/dL per hour 1, 2

Adjusting the Insulin Infusion

  • If glucose does not fall by 50 mg/dL in the first hour: verify adequate hydration status, then double the insulin infusion rate every hour until achieving steady decline of 50-75 mg/dL/hour 1, 2
  • When glucose reaches 250 mg/dL: reduce insulin to 0.05-0.1 units/kg/hour (2-4 units/hour) AND switch IV fluid to 5% dextrose with 0.45-0.75% saline 1, 2
  • Continue insulin infusion until complete DKA resolution, regardless of glucose levels 2

Concurrent Fluid and Electrolyte Management

Fluid Resuscitation

  • Begin with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour = 600-800 mL/hour for first hour 1, 2
  • Total fluid replacement should approximate 1.5 times 24-hour maintenance requirements 1

Potassium Management Throughout Treatment

This is where most errors occur:

  • If K+ 3.3-5.5 mEq/L: add 20-30 mEq/L potassium to each liter of IV fluid (use 2/3 KCl and 1/3 KPO₄) once urine output confirmed 1, 2
  • If K+ >5.5 mEq/L: withhold potassium initially but monitor closely every 2 hours, as insulin will drive it intracellularly rapidly 2
  • Target serum potassium: 4-5 mEq/L throughout treatment 2, 3
  • Total body potassium depletion averages 3-5 mEq/kg (120-200 mEq for this patient), and insulin therapy will unmask this depletion 3

Monitoring Requirements

  • Blood glucose: every 1-2 hours initially, then every 2-4 hours 1, 3
  • Serum electrolytes, pH, bicarbonate, anion gap: every 2-4 hours 1, 2
  • Potassium: every 2 hours during active treatment due to rapid shifts 3
  • Neurological status: continuously monitor for signs of cerebral edema (headache, altered mental status worsening, neurological deterioration) - this is more common in children and adolescents 3

DKA Resolution Criteria

DKA is resolved when ALL of the following are met 1, 2:

  • Glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3
  • Anion gap ≤12 mEq/L

Transition to Subcutaneous Insulin

This is the most common error leading to DKA recurrence:

  • Administer basal insulin (glargine or detemir) subcutaneously 2-4 hours BEFORE stopping IV insulin - this overlap is absolutely critical 1, 2, 3
  • For a 40 kg patient, start basal insulin at 0.5 units/kg/day = 20 units once daily (50% of total daily dose as basal) 3
  • Continue IV insulin for 1-2 hours after giving subcutaneous insulin 1
  • Never stop IV insulin without prior basal insulin administration 1, 3

Calculating Subcutaneous Doses

  • Total daily dose: Average hourly IV insulin rate from last 12 hours × 24 hours 3
  • Basal insulin: 50% of total daily dose given as long-acting insulin once daily 3
  • Prandial insulin: 50% of total daily dose divided equally before three meals as rapid-acting insulin 3

Critical Pitfalls to Avoid

  • Never start insulin if K+ <3.3 mEq/L - this causes fatal arrhythmias 1, 2
  • Never stop IV insulin before giving subcutaneous basal insulin - causes rebound hyperglycemia and recurrent DKA 1, 2, 3
  • Never interrupt insulin infusion when glucose falls - add dextrose to IV fluids instead and reduce insulin rate 2
  • Never use subcutaneous insulin in critically ill patients with altered mental status - IV insulin is the standard of care for this population 2
  • Never use correction-only (sliding scale) insulin without basal coverage - leads to worse outcomes 3

Special Considerations for Altered Mental Status

  • Continuous IV insulin at 0.1 units/kg/hour is the absolute standard of care for critically ill and mentally obtunded patients 2
  • Subcutaneous rapid-acting insulin analogs are only appropriate for hemodynamically stable, alert patients with mild-moderate DKA 1, 2, 5
  • Monitor closely for cerebral edema, which occurs more commonly in children and adolescents than adults 3

References

Guideline

Diabetic Ketoacidosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Assessment and Management of Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Insulin Dosing for Type 2 Diabetes with DKA and Infected Foot Ulcer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.